The FDA is set to decide by June 10 ... views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York, with ...

(RTTNews) - Ocugen, Inc. (OCGN) announced the FDA has granted Rare Pediatric Disease ... the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

Shares of Moderna MRNA declined nearly 8% yesterday after it announced that it had voluntarily withdrawn a regulatory filing seeking the FDA’s approval for mRNA-1083, its investigational mRNA ...

The FDA granted Breakthrough Therapy Designation ... and 0 firms issue sell ratings. , Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel ...

NEW YORK, May 19, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer ... the U.S. Food and Drug Administration (FDA) has cleared the company to initiate ...

KHINDIVI is the only FDA-approved oral solution formulation of ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New York ...

(RTTNews) - Amneal Pharmaceuticals (AMRX) announced that the FDA has approved Brekiya injection ... and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew ...

Incyte INCY announced that the FDA has approved its new drug, Zynyz (retifanlimab-dlwr), a PD-1 inhibitor, for treating a new cancer indication. The regulatory body has now approved Zynyz in ...

PRINCETON, N.J.--(BUSINESS WIRE)-- UroGen (NASDAQ: URGN), a biotech company dedicated ... today announced that the U.S. Food and Drug Administration (FDA) has scheduled an Oncologic Drugs Advisory ...

Until now, the vaccine had been available for use under the FDA’s emergency use authorization. Ahead of this milestone, uncertainty surrounded the approval timeline after HHS secretary Robert F.

(RTTNews) - Omeros Corporation (OMER) Tuesday said that the U.S. Food and Drug Administration (FDA) has accepted for ... not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s ...

ImmunityBio ( NASDAQ: IBRX) said on Monday that the U.S. FDA has approved expanded access for its Cancer BioShield platform, ...